Skip to content

A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial for the Efficacy and Safety of a Novel Nutraceutical for Mild-to-Moderate Acne.

Randomized controlled trial · J Cosmet Dermatol · 2025. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 40321085

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial for the Efficacy and Safety of a Novel Nutraceutical for Mild-to-Moderate Acne.

Draelos Z, Harper J, Farris PK et al.
J Cosmet Dermatol · 2025

PubMed ID
40321085
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.